J Proteins Counteract Amyloid Propagation and Toxicity in Yeast

Daniel C Masison1, Michael Reidy1, Jyotsna Kumar2

  • 1Laboratory of Biochemistry and Genetics, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD 20892, USA.

Biology
|September 23, 2022
PubMed

Insights

Misfolded proteins forming amyloids cause diseases like Alzheimer's. J-domain proteins (JDPs) help counteract amyloid toxicity in yeast by regulating protein quality control, often with Hsp70 chaperones.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Neuroscience

Background:

  • Amyloid protein accumulation is linked to neurodegenerative diseases such as Alzheimer's, Parkinson's, and Huntington's.
  • Yeast models are valuable for studying amyloid toxicity and cellular responses to misfolded proteins.

Purpose of the Study:

  • To explore protein quality control factors that counteract amyloid propagation and toxicity.
  • To emphasize the role of J-domain proteins (JDPs) in managing amyloidogenic proteins.

Main Methods:

  • Utilizing yeast as a model system to express human amyloid-forming proteins.
  • Investigating the function of J-domain proteins (JDPs) and their interaction with Hsp70 chaperones.

Main Results:

  • J-domain proteins (JDPs) are key regulators of Hsp70 chaperones and are abundant in yeast.
  • JDPs demonstrate anti-amyloid effects, either directly or through Hsp70 interaction.

Conclusions:

  • Protein quality control mechanisms, particularly JDPs, are crucial for mitigating amyloid toxicity.
  • Understanding JDPs and Hsp70 interactions offers potential therapeutic targets for amyloid-related diseases.